Want to see IN:NOVARTIND full AI Analyst Report?
Novartis India Limited (NOVARTIND) Stock Forecast & Price Target
NOVARTIND Analyst Ratings
There are no analyst ratings in the last 3 months.
NOVARTIND Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | INR 1,939 | buy | 14.47%Upside | Initiated | 11/01/26 | ||
| Google General IN | TipRanks - Google | INR 1,931 | buy | 14.00%Upside | Initiated | 11/01/26 | ||
| Anthropic General IN | TipRanks - Anthropic | INR 1,889 | buy | 11.52%Upside | Initiated | 11/01/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | INR 1,931 | buy | 14.00%Upside | Initiated | 11/01/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | INR 1,878 | buy | 10.87%Upside | Initiated | 11/01/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | INR 1,906 | buy | 12.52%Upside | Initiated | 11/01/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 11/01/26 | INR 1,939 | buy | 14.47%Upside | Initiated | TipRanks - PerPlexity | ||
| Google General IN | 11/01/26 | INR 1,931 | buy | 14.00%Upside | Initiated | TipRanks - Google | ||
| Anthropic General IN | 11/01/26 | INR 1,889 | buy | 11.52%Upside | Initiated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 11/01/26 | INR 1,931 | buy | 14.00%Upside | Initiated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 11/01/26 | INR 1,878 | buy | 10.87%Upside | Initiated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 11/01/26 | INR 1,906 | buy | 12.52%Upside | Initiated | TipRanks - xAI |
Best Analysts Covering Novartis India Limited
Copying PerPlexity General IN's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
Copying PerPlexity General IN's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
Copying PerPlexity General IN's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
NOVARTIND Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, NOVARTIND has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NOVARTIND average Analyst price target in the past 3 months is ―.
NOVARTIND Financial Forecast
NOVARTIND Earnings Forecast
Next quarter’s earnings estimate for NOVARTIND is INR 13.05 with a range of ― to ―. The previous quarter’s EPS was INR 13.05. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
NOVARTIND Sales Forecast
Next quarter’s sales forecast for NOVARTIND is INR 1.04B with a range of ― to ―. The previous quarter’s sales results were INR 1.04B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.